Kimia Farma Persero Tbk (JK:KAEF) — Market Cap & Net Worth
Market Cap & Net Worth: Kimia Farma Persero Tbk (KAEF)
Kimia Farma Persero Tbk (JK:KAEF) has a market capitalization of $146.78 Million (Rp2.50 Trillion) as of June 17, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #17830 globally and #262 in its home market, demonstrating a 10.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kimia Farma Persero Tbk's stock price Rp450.00 by its total outstanding shares 5566589677 (5.57 Billion). Review KAEF total liabilities to assess the company's total debt and financial obligations.
Kimia Farma Persero Tbk Market Cap History: 2015 to 2026
Kimia Farma Persero Tbk's market capitalization history from 2015 to 2026. Data shows change from $274.09 Million to $146.78 Million (-5.99% CAGR).
Index Memberships
Kimia Farma Persero Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$485.21 Billion | 0.03% | #255 of 864 |
Weight: Kimia Farma Persero Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Kimia Farma Persero Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kimia Farma Persero Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Kimia Farma Persero Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $872.23 Million | $5.81 Trillion | $267.41 Billion | 0.00x | 0.00x |
| 2017 | $859.75 Million | $6.13 Trillion | $326.79 Billion | 0.00x | 0.00x |
| 2018 | $834.43 Million | $7.45 Trillion | $415.90 Billion | 0.00x | 0.00x |
| 2019 | $403.06 Million | $9.40 Trillion | -$12.72 Billion | 0.00x | N/A |
| 2020 | $1.37 Billion | $10.01 Trillion | $17.64 Billion | 0.00x | 0.08x |
| 2021 | $783.93 Million | $12.86 Trillion | $302.27 Billion | 0.00x | 0.00x |
| 2022 | $353.91 Million | $9.23 Trillion | -$190.47 Billion | 0.00x | N/A |
| 2023 | $471.33 Million | $9.97 Trillion | -$1.49 Trillion | 0.00x | N/A |
| 2024 | $197.34 Million | $9.94 Trillion | -$842.27 Billion | 0.00x | N/A |
| 2025 | $167.98 Million | $9.22 Trillion | -$334.96 Billion | 0.00x | N/A |
Competitor Companies of KAEF by Market Capitalization
Companies near Kimia Farma Persero Tbk in the global market cap rankings as of June 17, 2026.
Key companies related to Kimia Farma Persero Tbk by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #274 globally with a market cap of $93.73 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #538 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #639 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1156 globally with a market cap of $22.87 Billion USD ( AU$32.32 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #274 | McKesson Corporation | NYSE:MCK | $93.73 Billion | $779.78 |
| #538 | Cencora Inc. | NYSE:COR | $50.53 Billion | $281.43 |
| #639 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $226.40 |
| #1156 | Sigma Healthcare Ltd | AU:SIG | $22.87 Billion | AU$2.80 |
Kimia Farma Persero Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Kimia Farma Persero Tbk's market cap moved from $274.09 Million to $ 146.78 Million, with a yearly change of -5.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp146.78 Million | -12.62% |
| 2025 | Rp167.98 Million | -14.88% |
| 2024 | Rp197.34 Million | -58.13% |
| 2023 | Rp471.33 Million | +33.18% |
| 2022 | Rp353.91 Million | -54.86% |
| 2021 | Rp783.93 Million | -42.80% |
| 2020 | Rp1.37 Billion | +240.00% |
| 2019 | Rp403.06 Million | -51.70% |
| 2018 | Rp834.43 Million | -2.95% |
| 2017 | Rp859.75 Million | -1.43% |
| 2016 | Rp872.23 Million | +218.23% |
| 2015 | Rp274.09 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Kimia Farma Persero Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $146.78 Million USD |
| MoneyControl | $146.78 Million USD |
| MarketWatch | $146.78 Million USD |
| marketcap.company | $146.78 Million USD |
| Reuters | $146.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceutical products in Indonesia and internationally. It offers generic drugs, ethical products, over-the-counter products, herbs, and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical produc… Read more